The North America Point of Care (POC) Diagnostics Market is witnessing rapid transformation driven by technological advancements, rising chronic disease prevalence, and the increasing demand for faster diagnostic results. According to market estimates, the North America Point of Care Diagnostics Market size is expected to reach US$ 34,026.8 Million by 2031, growing from US$ 15,289.0 Million in 2024, registering a CAGR of 12.2% from 2025 to 2031. The market is gaining strong momentum as healthcare systems increasingly adopt decentralized testing solutions that enable faster clinical decisions and improved patient outcomes.

Point-of-care diagnostics refers to medical testing performed near or at the site of patient care, such as clinics, emergency departments, pharmacies, or even at home. These solutions eliminate the need for centralized laboratory testing, significantly reducing turnaround time and enabling timely disease detection and treatment initiation.

Download Sample PDF Copy: https://www.theinsightpartners.com/sample/TIPRE00023729

Market Overview

The healthcare landscape in North America is rapidly shifting toward patient-centric, value-based care. Point-of-care diagnostics play a crucial role in this transformation by offering rapid, portable, and easy-to-use testing solutions. These technologies are widely used across infectious disease testing, cardiometabolic monitoring, pregnancy and fertility testing, blood glucose monitoring, and hematology testing.

The strong healthcare infrastructure in the US and Canada, combined with high healthcare expenditure and technological innovation, has created a favorable ecosystem for market growth. Furthermore, the rising adoption of home healthcare and telemedicine services is accelerating the demand for portable and remote diagnostic solutions.

Key Market Drivers

1. Rising Prevalence of Chronic and Infectious Diseases

One of the most significant drivers of the North America POC diagnostics market is the increasing burden of chronic diseases such as diabetes, cardiovascular disorders, respiratory diseases, and cancer. The growing aging population in the region further contributes to the demand for frequent monitoring and rapid testing solutions.

Additionally, the experience from the COVID-19 pandemic has reshaped the diagnostic landscape. Healthcare providers and governments now prioritize rapid testing capabilities to manage infectious disease outbreaks effectively. As a result, POC diagnostic devices have become essential tools for early detection and real-time monitoring of infectious diseases, including influenza, RSV, HIV, and sexually transmitted infections.

The growing need for continuous monitoring and early detection is expected to sustain the demand for point-of-care testing throughout the forecast period.

2. Growing Demand for Rapid and Decentralized Testing

Healthcare systems across North America are shifting from centralized laboratory testing toward decentralized healthcare delivery models. Point-of-care diagnostics enable immediate results, allowing physicians to make real-time clinical decisions.

Rapid testing reduces hospital visits, lowers healthcare costs, and improves patient satisfaction. In emergency and critical care settings, quick diagnostic results can be lifesaving. The ability to deliver accurate results within minutes is driving adoption across hospitals, urgent care centers, ambulatory surgical centers, and home healthcare settings.

Furthermore, retail clinics and pharmacies are increasingly offering diagnostic services, creating new growth opportunities for POC testing devices.

3. Technological Advancements in Diagnostic Devices

Technological innovation remains a cornerstone of market expansion. Advancements in biosensors, microfluidics, lab-on-a-chip technology, artificial intelligence, and connectivity are transforming point-of-care diagnostics.

Modern POC devices are becoming:

• More portable and user-friendly
• Highly accurate and sensitive
• Connected to cloud-based healthcare systems
• Capable of delivering multiplex testing

Integration of AI and digital health platforms enables real-time data sharing and remote patient monitoring. These innovations improve clinical workflow efficiency and enable healthcare providers to deliver personalized care.

The continuous evolution of smart diagnostic devices is expected to significantly accelerate market growth.

4. Increasing Adoption of Home Healthcare and Self-Testing

The rising preference for home healthcare is another major factor fueling market growth. Consumers increasingly seek convenient, at-home diagnostic solutions that allow them to monitor their health independently.

Devices such as glucose monitors, pregnancy tests, and rapid infectious disease test kits are witnessing strong adoption among consumers. The growing popularity of telehealth services further complements the use of at-home diagnostic tools.

This shift toward self-testing not only improves patient engagement but also reduces the burden on hospitals and laboratories.

5. Favorable Government Initiatives and Healthcare Investments

Government initiatives supporting early disease detection and preventive healthcare are contributing significantly to market expansion. North America has witnessed substantial investments in diagnostic infrastructure, research, and innovation.

Regulatory agencies are increasingly streamlining approval processes for innovative diagnostic technologies, encouraging manufacturers to introduce advanced POC solutions in the market. Public health programs promoting screening and early diagnosis are also driving adoption.

6. Cost Efficiency and Healthcare System Optimization

Point-of-care diagnostics help reduce healthcare costs by minimizing hospital admissions, shortening hospital stays, and preventing disease progression through early detection. These benefits make POC testing an attractive option for healthcare providers, insurers, and patients alike.

The cost-effectiveness of decentralized testing is encouraging healthcare systems to incorporate POC solutions into routine clinical workflows.

Market Segmentation Insights

The market is broadly segmented by product, platform, application, and end user. Among these, infectious disease testing and glucose monitoring dominate the market due to their widespread clinical use and high demand.

Hospitals and clinics remain the largest end users; however, home healthcare and ambulatory care centers are expected to experience the fastest growth during the forecast period.

Competitive Landscape and Top Players

The North America Point of Care Diagnostics Market is highly competitive, with key players focusing on product innovation, partnerships, and strategic acquisitions. Leading companies operating in the market include:

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Siemens Healthineers AG
• Danaher Corporation
• Becton, Dickinson and Company
• QuidelOrtho Corporation
• Bio-Rad Laboratories, Inc.
• Nova Biomedical
• EKF Diagnostics Holdings plc
• Trinity Biotech plc

These companies are continuously investing in research and development to launch next-generation diagnostic solutions that offer higher accuracy, portability, and connectivity.

Future Outlook

The future of the North America Point of Care Diagnostics Market looks highly promising. The growing emphasis on personalized medicine, preventive healthcare, and digital health integration will continue to create lucrative opportunities.

By 2031, point-of-care testing is expected to become a standard component of healthcare delivery, enabling faster diagnosis, improved patient outcomes, and enhanced healthcare efficiency.

About Us

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us

Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876